"The U.S. Food and Drug Administration recently approved Oralair to treat allergic rhinitis (hay fever) with or without conjunctivitis (eye inflammation) that is induced by certain grass pollens in people ages 10 through 65 years. Oralair is the f"...
Topical Ophthalmic Use Only
For topical ophthalmic administration only.
Sterility of Dropper Tip Patients should be advised to not touch dropper tip to any surface, as this may contaminate the contents.
Concomitant Use of Contact Lenses
Patients should be advised not to wear a contact lens if their eyes are red. Patients should be advised that PATADAY™ (olopatadine hydrochloride ophthalmic solution) solution should not be use to treat contact lens-related irritation. Patients should also be advised to remove contact lenses prior to instillation of PATADAY™ (olopatadine hydrochloride ophthalmic solution) solution. The preservative in PATADAY™ (olopatadine hydrochloride ophthalmic solution) solution benzalkonium chloride may be absorbed by soft contact lenses. Lenses may be reinserted following administration of PATADAY™ (olopatadine hydrochloride ophthalmic solution) solution.
Last reviewed on RxList: 1/27/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Pataday Information
Pataday - User Reviews
Pataday User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.